136 related articles for article (PubMed ID: 20734456)
1. Hospitalizations with healthcare-associated complicated skin and skin structure infections: impact of inappropriate empiric therapy on outcomes.
Zilberberg MD; Shorr AF; Micek ST; Chen J; Ramsey AM; Hoban AP; Pham V; Doherty JA; Mody SH; Kollef MH
J Hosp Med; 2010; 5(9):535-40. PubMed ID: 20734456
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections: implications of healthcare-associated infection risk factors.
Zilberberg MD; Shorr AF; Micek ST; Hoban AP; Pham V; Doherty JA; Ramsey AM; Kollef MH
Infect Control Hosp Epidemiol; 2009 Dec; 30(12):1203-10. PubMed ID: 19848604
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for mixed complicated skin and skin structure infections to help tailor appropriate empiric therapy.
Zilberberg M; Micek ST; Kollef MH; Shelbaya A; Shorr AF
Surg Infect (Larchmt); 2012 Dec; 13(6):377-82. PubMed ID: 23216526
[TBL] [Abstract][Full Text] [Related]
4. Economic outcomes of inappropriate initial antibiotic treatment for complicated skin and soft tissue infections: a multicenter prospective observational study.
Lipsky BA; Napolitano LM; Moran GJ; Vo L; Nicholson S; Chen S; Boulanger L; Kim M
Diagn Microbiol Infect Dis; 2014 Jun; 79(2):266-72. PubMed ID: 24657171
[TBL] [Abstract][Full Text] [Related]
5. Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).
Amara S; Adamson RT; Lew I; Huang X
Curr Med Res Opin; 2013 Jul; 29(7):869-77. PubMed ID: 23659559
[TBL] [Abstract][Full Text] [Related]
6. Resource use in patients hospitalized with complicated skin and soft tissue infections in Europe and analysis of vulnerable groups: the REACH study.
Ostermann H; Blasi F; Medina J; Pascual E; McBride K; Garau J;
J Med Econ; 2014 Oct; 17(10):719-29. PubMed ID: 24983206
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of empiric antimicrobial treatments for skin and soft tissue infections in newly hospitalized patients.
Yazdani C; Hanna N
J Pharm Pract; 2014 Feb; 27(1):53-60. PubMed ID: 24076599
[TBL] [Abstract][Full Text] [Related]
8. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
[TBL] [Abstract][Full Text] [Related]
9. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
[TBL] [Abstract][Full Text] [Related]
10. Outcomes associated with initial versus later vancomycin use in patients with complicated skin and skin-structure infections.
Itani KM; Akhras KS; Stellhorn R; Quintana A; Budd D; Merchant S
Pharmacoeconomics; 2009; 27(5):421-30. PubMed ID: 19586079
[TBL] [Abstract][Full Text] [Related]
11. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges.
Cosgrove SE; Qi Y; Kaye KS; Harbarth S; Karchmer AW; Carmeli Y
Infect Control Hosp Epidemiol; 2005 Feb; 26(2):166-74. PubMed ID: 15756888
[TBL] [Abstract][Full Text] [Related]
12. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
Shorr AF; Combes A; Kollef MH; Chastre J
Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656
[TBL] [Abstract][Full Text] [Related]
13. Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock.
Vazquez-Guillamet C; Scolari M; Zilberberg MD; Shorr AF; Micek ST; Kollef M
Crit Care Med; 2014 Nov; 42(11):2342-9. PubMed ID: 25072764
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.
Bassetti M; Trecarichi EM; Mesini A; Spanu T; Giacobbe DR; Rossi M; Shenone E; Pascale GD; Molinari MP; Cauda R; Viscoli C; Tumbarello M
Clin Microbiol Infect; 2012 Sep; 18(9):862-9. PubMed ID: 21999245
[TBL] [Abstract][Full Text] [Related]
15. Empiric antibiotics and outcomes of children hospitalized with eczema herpeticum.
Aronson PL; Yan AC; Mohamad Z; Mittal MK; Shah SS
Pediatr Dermatol; 2013; 30(2):207-14. PubMed ID: 22994962
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients.
Zervos MJ; Freeman K; Vo L; Haque N; Pokharna H; Raut M; Kim M
J Clin Microbiol; 2012 Feb; 50(2):238-45. PubMed ID: 22116149
[TBL] [Abstract][Full Text] [Related]
17. Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain.
Tellado JM; Sen SS; Caloto MT; Kumar RN; Nocea G
Scand J Infect Dis; 2007; 39(11-12):947-55. PubMed ID: 17852889
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience.
Sakoulas G; Brown J; Lamp KC; Friedrich LV; Lindfield KC
Clin Ther; 2009 Sep; 31(9):1936-45. PubMed ID: 19843483
[TBL] [Abstract][Full Text] [Related]
19. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
Kopp BJ; Nix DE; Armstrong EP
Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
[TBL] [Abstract][Full Text] [Related]
20. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
